Molina Healthcare, Inc.
209.15USD
-7.4900 (-3.46%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MOH.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 32.0B | 34.1B | 40.7B | 45.4B | 44.6B | 47.5B |
| Q1 | 7.8B | 8.1B | 9.9B | 11.1B | 10.8B | 11.7B |
| Q2 | 8.1B | 8.3B | 9.9B | 11.4B | 10.9B | — |
| Q3 | 7.9B | 8.5B | 10.3B | 11.5B | 11.1B | — |
| Q4 | 8.2B* | 9.0B* | 10.5B* | 11.4B* | 11.8B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 13.55 | 18.77 | 20.42 | 8.92 | 5.28 | 9.66 |
| Q1 | 4.39 | 5.52 | 5.17 | 5.45 | .270 | 3.01 |
| Q2 | 4.25 | 5.35 | 5.17 | 4.75 | 1.19 | — |
| Q3 | 3.95 | 4.21 | 5.65 | 1.51 | .730 | — |
| Q4 | .957* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| 3.72* |
| 4.35* |
| -3.02* |
| .510 |
| — |
Debt level and coverage